Sameer Goel: Taking Innovative Business Decisions For His Organization's Optimal Growth | CEOInsights Vendor
Separator
Sameer Goel: Taking Innovative Business Decisions For His Organization's Optimal Growth

Sameer Goel: Taking Innovative Business Decisions For His Organization's Optimal Growth

Separator
Sameer Goel,Managing Director

Sameer Goel

Managing Director

A pioneer in the Indian biosciences industry and leveraging his business expertise and industry experience, Sameer Goel has been able to guide Kimia Biosciences to greater heights in the biosciences industry. Under his guidance, the firm has been able to build a positive reputation in the industry and carve out a niche in the market.

In an exclusive interview with CEO INSIGHTS, Sameer talks more about his professional journey and the operations of Kimia Biosciences.

1. Give us a brief detail about your educational and professional background and how has it helped you in your journey so far?
I have pursued Bachelor in Commerce which has contributed a lot to the development of my Entrepreneurial, Teamwork and Leadership skills. In 2001, I established a Trading Company Biotavia due to which I gained lot of insights about API business. Continuous motivation to grow further led me into establishing Kimia Biosciences in 2012. Set up as an API & Intermediate Business, the establishment of Kimia has challenged me to convert a Sick Intermediate manufacturing Unit into a well-established manufacturing unit as per GMP. Now, I want to see Kimia as the fastest growing company in API for both regulated, semi regulated and non-regulated markets.

2. As the MD, what different roles & responsibilities have you been undertaking at the company and how does your experience help you to chalk-out efficient business strategies?
As MD of the company, the different roles and responsibilities which I undertake include successfully implementing company policy, developing strategic plans, maintaining a dialogue between shareholders and the board, controlling finance, building and maintaining an effective management team and assuming full accountability for the board for all company operations.
Our business modules involve the discovery & Manufacturing of API & Intermediates that achieve substantial global sales. Our business model can be viewed as a framework that considers the technological characteristics and potentials of the company as inputs which are built on key resources, key partners and key activities of the company. And further converts these inputs into valuable economic output through the customer relationship, target customer segments.

3. How does Kimia Biosciences Ltd stand unique in the market when compared to its peers? Also, can you tell us about the R&D and infrastructural facilities in your organization?
We have an established track record in the Pharma business with a focus on low to medium volume and high-value products. We have specialization in multiple therapeutic areas including- Central Nervous System, Cardiovascular, Anti- Diabetic, Anti- Coagulant, GIT and Nutraceutical Substance having tremendous future growth potential. By virtue of this niche focus, we have registered an impressive growth.

The corporate realm is a highly competitive place and to be successful, one should have a solid business plan, prepare for financial challenges, be frugal, develop networking skills, never stop learning, and safeguard your venture


Our R&D team and facility is well established in Gurugram, Haryana and it is approved by the Department of Scientific and Industrial Research, and Ministry of Science & Technology government of India. We have a novel laboratory for research, Innovation & Optimization in API manufacturing process and expertise in Patent Scanning & Developing non infringing processes. We have also filled various Process Patents. We are also experts in Process Chemistry, Analytical Development, Regulatory affairs, Intellectual property, Process scale and collaborative programs under confidentiality agreements.

4. What strategies are you devising to reach a stronger position in the Biotechnology domain?
Our strategy going forward is to
further consolidate our pre-eminent position in the high growth therapeutic areas by expanding our capacity for present advanced intermediates and moving up the value chain by expanding capacity for APIs and diversifying product portfolio into the other high growth therapeutic areas like Anti-diabetic, Anti-coagulants, Anti-fungal, Vitamins, Anti- hypertensive, Antipsychotic, Anti –bacterial, Anti-histamine and Cholelithiasis agent. While over 75% of our revenue is from Domestic Regulated markets at present and now kimia strategically establishing the business in Semi Regulated and Regulated Markets.

5. In your professional journey so far, which are the milestones that bestowed you with utmost satisfaction - both as an individual and as an MD?
Serving Pharmaceutical companies API of the best quality gives me the utmost satisfaction as it helps in providing patients healthy & happy life. Second, providing healthy environment to my employees for their growth & development so that they can deliver the best quality to my customer. Our biggest achievement of last year is that we have, filled 1st KFDA for 2 products and further planned to fill 5 more products by the upcoming financial year. We have also the Received Environment management award and ICC Award for excellence in Management of Health and safety as well.

Apart from this, I have also been awarded on numerous occasions including – India business leader award, Best Exporter Award, Best Export of Chemical products award and Trading House Award to name a few.

6. What advice would you like to give to the young entrepreneurs in India and what would tell them to expect in their journey?
The corporate realm is a highly competitive place and to be successful, one should have a solid business plan, prepare for financial challenges, be frugal, develop networking skills, never stop learning, and safeguard your venture. Hurdles and failures come in every business so every entrepreneur should be prepared for it and also, they should have a good backup financial plan.

Sameer Goel, MD, Kimia Biosciences
Leading the business growth of the company from the front, Sameer has been able to play multiple important roles in the success of the organization and still remain humble in that success.

Trending Stories


🍪 Do you like Cookies?

We use cookies to ensure you get the best experience on our website. Read more...